Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program

By sjmartinez • January 23, 2024

Kanise H, van Oosterhout JJ, Bisani P, Songo J, Matola BW, Chipungu C, Simon K, Cox C, Hosseinipour MC, Sagno JB, Hoffman RM, Wallrauch C, Phiri S, Steegen K, Jahn A, Nyirenda R, Heller T. Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program. Viruses. 2023 Dec 23;16(1):29. doi: 10.3390/v16010029. PMID: 38257730.

Tags: antiretroviral therapy, dolutegravir, Drug resistance, HIV, Infectious Diseases, Malawi, mutations, Outcomes, Publications

Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis

GBD 2021 Global Sepsis Collaborators. Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis. Lancet Glob Health. 2025 Dec;13(12):e2013-e2026. doi: 10.1016/S2214-109X(25)00356-0. Epub[...]

Using generative AI for healthcare-associated infection surveillance

Morgan DJ, Goodman KE, Branch-Elliman W, Shenoy ES, Salinas JL, Jones M, Singh SP, Schrank GM, Pineles L, AlShanqeeti S, Harris AD, Klein E. Using[...]

Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum

Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson P, Myer L, Celum C, Heffron R, Coleman J, Davey DJ, Hendrix[...]